Funding Tracker/Aevius
Launch funding · Clinical AI & Documentation · United States
Aevius raises $22M
Announced November 17, 2026
The round
Aevius announced a Launch funding round of $22M on November 17, 2026, led by Insight Partners.
The SignalAevius, a Mass General Brigham spinout, launched with $22 million in funding led by Insight Partners to support model and product development, team expansion and commercial deployment of its multimodal patient representation.
What Aevius does
Mass General Brigham spinout building AI models that make medicine computable.
Aevius is a clinical intelligence company and Mass General Brigham spinout, founded to make medicine computable. It develops AI models that learn from structured, unstructured and specialty multimodal medical data, including medical records and imaging, to create a refreshable multimodal patient representation that can be updated as new information arrives. Organizations can use it to forecast outcomes, find clinically similar patients, identify and stratify populations and monitor change over time. Aevius is bringing the technology to health systems, payers and life sciences companies. On November 17, 2026, it launched with $22 million in funding led by Insight Partners.
Full Aevius profile- Company
- Aevius
- Amount
- $22M
- Stage
- Launch funding
- Announced
- November 17, 2026
- Led by
- Insight Partners
- Vertical
- Clinical AI & Documentation
- Country
- United States
- Headquarters
- Boston, MA, United States
More Clinical AI & Documentation rounds
Your daily HealthTech Signal
No hype. Just signal.
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: